46 Recruiting Esophageal Adenocarcinoma Clinical Trials
Explore open interventional and observational research studies actively enrolling participants across the USA. Verify eligibility and contact site coordinators directly.
📍 Find Near Me by DistanceBrowse by State
Browse by Study Phase
Top Interventions for Esophageal Adenocarcinoma
Related Conditions
Top Recruiting Esophageal Adenocarcinoma Studies
🔵 Active, Not Recruiting Phase1 / Phase2 💊 Investigational Drug / Biologic
Durvalumab, an Anti-PDLI Antibody, and Tremelimumab, an Anti-CTLA4 Antibody, and Chemoradiation Before Surgery for Esophageal Cancer
📍 Memorial Sloan Kettering Basking Ridge — Basking Ridge, New Jersey
View Study & Checklist ➔ 🔵 Active, Not Recruiting Phase2 💊 Investigational Drug / Biologic
Adjuvant Trastuzumab Deruxtecan (Enhertu) & Nivolumab For Patients Who Are Disease Free After Completion of Trimodality Treatment For HER-2+ Cancers of Esophagus & Gastroesophageal Junction
📍 Weill Cornell Medicine/New York-Presbyterian — New York, New York
View Study & Checklist ➔ 🔵 Active, Not Recruiting Phase2 💊 Investigational Drug / Biologic
Study of Pembrolizumab in Locally Advanced Esophageal Adenocarcinoma
📍 USC Keck School of Medicine, Norris Cancer Center — Los Angeles, California
View Study & Checklist ➔ 🟡 Not Yet Recruiting Phase2 💊 Investigational Drug / Biologic
Upfront Chemotherapy With Radiation Therapy (CRT) Followed by Chemotherapy in Localized Esophageal Adenocarcinoma
📍 Duke University Medical Center — Durham, North Carolina
View Study & Checklist ➔ 🟢 Recruiting Phase2 💊 Investigational Drug / Biologic
Oxaliplatin and Liposomal Irinotecan (Plus Trastuzumab for HER2-positive Disease) in Advanced Esophageal and Gastric Adenocarcinoma
📍 University of Wisconsin Carbone Cancer Center — Madison, Wisconsin
View Study & Checklist ➔ 🟢 Recruiting Phase2 💊 Investigational Drug / Biologic
A Phase II Trial to Evaluate the Effect of Itraconazole on Pathologic Complete Response Rates in Resectable Esophageal Cancer
📍 VA Palo Alto Health Care System, Palo Alto, CA — Palo Alto, California
View Study & Checklist ➔ 🟢 Recruiting Phase2 💊 Investigational Drug / Biologic
Study of Suratadenoturev (OBP-301) in Combination With Pembrolizumab in Esophagogastric Adenocarcinoma
📍 Weill Cornell Medicine/NewYork-Presbyterian Hospital — New York, New York
View Study & Checklist ➔ 🟢 Recruiting Phase2 💊 Investigational Drug / Biologic
Propranolol With Standard Chemoradiation for Esophageal Adenocarcinoma
📍 Roswell Park Cancer Institute — Buffalo, New York
View Study & Checklist ➔ 🟢 Recruiting Phase2 🩺 Clinical Procedure Protocol
Liquid Nitrogen Spray Cryotherapy Prior to Neoadjuvant Systemic Therapy in Esophageal Adenocarcinoma
📍 Cleveland Clinic Florida — Weston, Florida
View Study & Checklist ➔